Anavex Life Sciences Corp (AVXL)

[Investor2014]

Below from December 2018 10Q, which does not appear in the recent 10Q.
So might that just be another way of saying:

Research and Development Incentive Income



The Company is eligible to obtain a research and development tax credit from the Australian Tax Authority (the “ATO”) for certain research and development activities undertaken in Australia. The tax incentive is available on the basis of specific criteria with which the Company must comply. Although the tax incentive is administered through the ATO, the Company has accounted for the tax incentive outside of the scope of ASC Topic 740, Income Taxes since the incentive is not linked to the Company’s income tax liability and can be realized regardless of whether the Company has generated taxable income in Australia. The Company recognizes as other income the amount received for qualified expenses in the period they are received.

Which also appears in the accounts as

Research and development incentive income	 	 	1,629,513	 	 	 	—	 	 	 	1,629,513	 	 	 	2,022,902	 

in the accounts of the December 10Q, but not in the recent 10Q.

My guess in no Tax Incentive was recognised in last period, but was at year end from Australian. So it is Anavex's way of saying we still have that third party funding commitment.